Log in or Sign up for Free to view tailored content for your specialty!
Anaphylaxis News
Nasal epinephrine spray outcomes comparable with autoinjector, manual injections
An intranasal epinephrine spray produced pharmacokinetic and pharmacodynamic results that were comparable or superior to intramuscular injections, according to a study published in The Journal of Allergy and Clinical Immunology: Global.
VIDEO: FDA-requested study of epinephrine nasal spray underway
ANAHEIM, Calif. — ARS Pharma is conducting an additional clinical trial of its neffy epinephrine nasal spray per FDA request, company cofounder, president and CEO Richard Lowenthal, MS, MSEL, told Healio.
Log in or Sign up for Free to view tailored content for your specialty!
Joint task force releases anaphylaxis, atopic dermatitis treatment parameters
Two new practice parameters from a joint task force published in Annals of Allergy, Asthma & Immunology provide evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis.
Customer discovery reveals why patients do not carry their epinephrine autoinjectors
ANAHEIM, Calif. — Inconvenience and forgetfulness are among the reasons why people do not always carry their epinephrine autoinjectors, according to a poster at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Epinephrine concentrations after injection decrease with greater BMI
ANAHEIM, Calif. — There was a significant negative relationship between epinephrine exposure via injection and BMI, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Top news of November: Multi-food immunotherapy, climate crisis, COVID-19, more
Healio compiled the most-read news in allergy, asthma and immunology posted in November.
VIDEO: Evolution of anaphylaxis guidelines, therapies
ANAHEIM, Calif. — The future of anaphylaxis guidelines and treatments are evolving, Jay A. Lieberman, MD, FACAAI, told Healio at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
VIDEO: ARS Pharma presents four epinephrine studies at ACAAI Annual Meeting
ANAHEIM, Calif. — ARS Pharma, which is developing the neffy nasal spray as an alternative to epinephrine injections for anaphylaxis, presented four studies at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
School health assistants fall short in anaphylaxis treatment knowledge
ANAHEIM, Calif. — Despite training, school personnel may not know how to administer epinephrine to children with anaphylaxis, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
ChatGPT accurately, yet sometimes inconsistently, debunks many allergy myths
ANAHEIM, Calif. — ChatGPT answered accurately or somewhat accurately 91% of the time when asked about 10 allergy myths, according to a study presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read